Treatment of ulcer disease.
D000535:Aluminum / Q000627:therapeutic use; D000863:Antacids / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use; D002927:Cimetidine / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005744:Gastric Acid / Q000378:metabolism; D006801:Humans; D009853:Omeprazole; D010437:Peptic Ulcer / Q000188:drug therapy* / Q000378:metabolism; D011899:Ranitidine / Q000009:adverse effects / Q000627:therapeutic use; D013392:Sucralfate
D000863:Antacids; D000897:Anti-Ulcer Agents; D001562:Benzimidazoles; D013392:Sucralfate; D002927:Cimetidine; D011899:Ranitidine; D000535:Aluminum; D009853:Omeprazole